Skip to content

To Study The Effectiveness Of Iris Versicolor In Acute Migraine Among Adults

Effectiveness Of Iris Versicolor In Management Of Acute Migraine Among Adults- A Non Controlled Experimental Study - Migraine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112574
Enrollment
32
Registered
2026-06-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G430- Migraine without aura

Interventions

Intervention1: IRIS VERSICOLOR: Homoeopathic remedy Iris Versicolor will be administered orally in globule form as per Homoeopathic principles in appropriate potency i.e potencies above 3c according t

Sponsors

Dr Asmita Bhoir
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinically Pre diagnosed Patients Of Acute Migraine Of Adult Age Group 25 Years to 45 Years In Which IRIS VERSICOLOR Is Indicated 2.Patients of Both the Genders 3.Patients From Different Socioeconomic Backgrounds Will be Considered. 4.Patients Willing TO Give The Written Consent Form

Exclusion criteria

Exclusion criteria: 1.Patients Of Acute Migraine Not Improving After 3 Months Of Treatment Will Be Excluded. 2.Patients developing Complications Of Migraine Like Chronic Migraine, Basilar Migraine, Vestibular Migraine or Other Complications Such As Migrainous Infarction, Migralepsy Will Be Excluded. 3.Suspected Immunocompromised Patients Will Be Excluded. 4.Pregnant and Lactating Females Will Be Excluded. 5.Patient With Certain Addiction Like Tobacco, Alcohol, Cigarettes,Bidis, Ganja will be excluded. 6.Patient Ongoing Any Other Treatment For Acute Migraine will be excluded. 7. Patients With Serious Primary Diseases Such As Cardiovascular,Liver,Kidney and Haematopoetic Systems and Other Organic Diseases will be Excluded.

Design outcomes

Primary

MeasureTime frame
Outcome Will Be Assessed In Terms Of Reduction In Pain And Frequency Of Acute Migraine Attacks based On VAS Scale ScoreTimepoint: Outcome Will Be Assessed In Terms Of Reduction In Pain at base, after 3 - 4 days of attack , 15 days , 1 month and 3months.

Secondary

MeasureTime frame
To Assess The Causal Relationship Between The Homoeopathic intervention and the Ultimate Clinical Outcome MODIFIED NARANJO CRITERIA FOR HOMOEOPATHY Will be usedTimepoint: Outcome will be assessed 15 days after Homoeopathic Intervention and after 3 months.

Countries

India

Contacts

Public ContactDr Neelam Wayal

Dr G D Pol Foundation Y M T Homoeopathic Medical College Hospital and PG Institute

neelamaswale@yahoo.com9930782083

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026